• Kyodo

  • SHARE

The U.S. Food and Drug Administration has issued a warning that Daiichi Sankyo Co.’s blood pressure agent Benicar and its similar variants can cause severe chronic diarrhea and substantial weight loss.

The warning applies to olmesartan medoxomil drugs marketed as Benicar, Benicar HTC, Azor and Tribenzor, the FDA said in a safety information bulletin Tuesday.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW